We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Daniel
Altmann
d.altmann@ic.ac.uk
Daniel
Altmann
d.altmann@ic.ac.uk
More information about this study, what is involved and how to take part can be found on the study website.
Provisional assignment of new diseases of uncertain etiology
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
Since the start of the COVID-19 pandemic, our research laboratory has been at the forefront of analysis of immunity to SARS-CoV-2, producing evidence on the nature and durability of protective immunity after natural infection of vaccination. We now plan a study to compare aspects of immunity between people who have made a good recovery from infection and those who suffer persistent symptoms - Long Covid. To do this we will recruit volunteers and take blood samples on two separate occasions. They will also complete a short questionnaire which will enable us to benchmark immune parameters against symptoms of Long Covid. In some cases we may also request a 6-minute walk-test with oximetry - that is, using oxygen desaturation as a gauge of respiratory function. In some cases we may request a stool sample to test for PCR-amplifiable virus copies. The work has been funded by NIHR with the aim that, by studying the defining immune parameters, we will be able to generate new, diagnostic tests. This would supply urgently needed, objective, test criteria for clinical referral, as well as pointing the way to therapeutic approaches.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Observational type: Cohort study;
You can take part if:
You may not be able to take part if:
Individuals will be excluded if they fall outside the above criteria or if they are unable to understand the patient information sheet or give consent.
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Daniel
Altmann
d.altmann@ic.ac.uk
Daniel
Altmann
d.altmann@ic.ac.uk
More information about this study, what is involved and how to take part can be found on the study website.
The study is sponsored by Imperial College of Science, Technology and Medicine and funded by NIHR / UKRI .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 50900
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
